Article
Targeting <i>ZC3H12C</i> improves T cell persistence and antitumor function in adoptive T cell therapy
2026-05-02
Abstract excerpt
Adoptive T cell therapy (ACT) has achieved remarkable clinical responses in hematologic malignancies but remains limited by progressive T cell dysfunction under chronic antigen stimulation. Here, we identify ZC3H12C as a conserved feature of dysfunctional T cells and show that its disruption enhances the durability and antitumor activity of engineered T cells. By integrating single-cell chromatin accessibility an...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 91748b66-73f7-57c2-84d1-96c02d11e0b6
- DOI
- 10.64898/2026.04.30.721618
